NFG
ALXN

Next Financial Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Next Financial Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-48
Closed -$8K – 2866
2021
Q2 		$8K Buy
48
+46
+2,300% +$7.9K ﹤0.01% 2085
2021
Q1 		$0 Sell
2
-2
-50% -$309 ﹤0.01% 2677
2020
Q4 		$1K Hold
4
– – ﹤0.01% 2332
2020
Q3 		$0 Buy
+4
New +$432 ﹤0.01% 2233
2020
Q2 		– Sell
-181
Closed -$16K – 2094
2020
Q1 		$16K Sell
181
-245
-58% -$24K ﹤0.01% 1376
2019
Q4 		$46K Hold
426
– – ﹤0.01% 1224
2019
Q3 		$42K Buy
426
+150
+54% +$16.9K ﹤0.01% 1197
2019
Q2 		$36K Buy
+276
New +$35.6K ﹤0.01% 1277
2018
Q4 		– Sell
-190
Closed -$26K – 2149
2018
Q3 		$26K Buy
+190
New +$23.8K 0.01% 712
2017
Q4 		– Sell
-240
Closed -$34K – 1570
2017
Q3 		$34K Hold
240
– – 0.01% 827
2017
Q2 		$29K Hold
240
– – 0.01% 957
2017
Q1 		$31K Sell
240
-98
-29% -$12.6K 0.01% 898
2016
Q4 		$41K Sell
338
-1,185
-78% -$145K 0.01% 1050
2016
Q3 		$187K Buy
1,523
+417
+38% +$53.7K 0.03% 485
2016
Q2 		$129K Buy
1,106
+440
+66% +$62.4K 0.04% 397
2016
Q1 		$92K Buy
666
+205
+44% +$30.1K 0.03% 448
2015
Q4 		$87K Buy
461
+71
+18% +$12.4K 0.03% 462
2015
Q3 		$60K Hold
390
– – 0.02% 580
2015
Q2 		$70K Hold
390
– – 0.02% 573
2015
Q1 		$67K Hold
390
– – 0.02% 584
2014
Q4 		$72K Hold
390
– – 0.02% 545
2014
Q3 		$65K Hold
390
– – 0.01% 828
2014
Q2 		$62K Buy
+390
New +$61.6K 0.03% 310

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Next Financial Group's ALXN Position: Q3 2021 in Review

Next Financial Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 48 shares — an estimated $8K sold.

Next Financial Group first reported a position in ALXN in Q2 2014 and held it in 23 quarters. The position peaked at $187K in Q3 2016. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Next Financial Group reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Next Financial Group sold 48 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8K.
  • Next Financial Group first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 23 quarters.
  • Next Financial Group's Alexion Pharmaceuticals position peaked at $187K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Next Financial Group's 13F filing for Q3 2021, filed 15 Oct 2021.